Physician profile
Ian Katz
NPI 1033128632
$5,495.99
in general payments reported to CMS, 2019-2025
10 companies · $15.25 in 2025
The $15.25 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $44.70 · 2021: $20.54 · 2022: $1,575 · 2023: $48.37 · 2024: $2,885 · 2025: $15.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,307 · Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,307.22 |
| Food and Beverage | $641.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $2,415.69 | 2019-2024 | |
| Stryker Corporation | $1,793.01 | 2024-2025 | Mako |
| Arthrex, INC. | $645.30 | 2019-2024 | |
| Innovation Technologies INC | $303.30 | 2022-2023 | Irrisept |
| Ethicon US, LLC | $126.12 | 2019 | |
| Depuy Synthes Sales INC. | $76.86 | 2019 | |
| Abbott Laboratories | $50.46 | 2022 | |
| Zimmer Biomet Holdings, INC. | $44.70 | 2020 | |
| Medical Device Business Services, INC. | $20.54 | 2021 | |
| Conmed Corporation | $20.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.